Susan Sloan
Nurse Practitioner · Science Hill, KYNPI 1134508880
Payments from drug & device makers
Across 445 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$728
- AbbVie$634
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$598
- Novo Nordisk$489
- Lilly USA, LLC$297
- Pfizer$284
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,60997%
- Education$1853%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 86 | $728 |
| AbbVie | 49 | $634 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 65 | $598 |
| Novo Nordisk | 41 | $489 |
| Lilly USA, LLC | 21 | $297 |
| Pfizer | 27 | $284 |
| Ironshore Pharmaceuticals Inc. | 15 | $275 |
| Astellas Pharma US Inc | 5 | $223 |
| AstraZeneca | 13 | $219 |
| Amgen(2 entities) | 14 | $194 |
| Bayer | 10 | $177 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $173 |
| Abbott | 8 | $147 |
| Vanda Pharmaceuticals Inc. | 6 | $139 |
| GSK | 8 | $131 |
| Novartis | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $117 |
| Merck | 6 | $107 |
| Sanofi-aventis U.S. LLC | 6 | $101 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 5 | $71 |
| Mylan Specialty L.p. | 4 | $69 |
| Sunovion Pharmaceuticals Inc. | 6 | $68 |
| Alkermes, Inc. | 3 | $61 |
| Exact Sciences | 3 | $46 |
| Shield Therapeutics Inc | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Boehringer Ingelheim | 3 | $38 |
| Viatris Specialty LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Corium, LLC | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
How this compares
$5,794 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 148 | $167,439 |
| JardianceEmpagliflozin | 117 | $96,492 |
| OzempicSemaglutide | 84 | $84,409 |
| EliquisApixaban | 59 | $38,773 |
| FarxigaDapagliflozin Propanediol | 48 | $30,291 |
| LinzessLinaclotide | 35 | $22,257 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $20,624 |
| JanuviaSitagliptin Phosphate | 16 | $20,386 |
| TrulancePlecanatide | 24 | $18,354 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $15,294 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $14,500 |
| UbrelvyUbrogepant | 12 | $13,965 |
| Nurtec OdtRimegepant Sulfate | 14 | $13,745 |
| RybelsusSemaglutide | 11 | $10,385 |
| Emgality PenGalcanezumab-Gnlm | 13 | $9,023 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $297 | $167,439148 claims |
| Boehringer IngelheimJardiance | $38 | $96,492117 claims |
| Novo NordiskOzempic, Rybelsus | $489 | $94,79495 claims |
| PfizerEliquis, Nurtec Odt | $284 | $52,51873 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $219 | $50,91473 claims |
| AbbVieLinzess, Ubrelvy | $634 | $36,22247 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $131 | $29,79453 claims |
| MerckJanuvia | $107 | $20,38616 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $598 | $18,35424 claims |
| Astellas Pharma US IncVeozah, Myrbetriq | $223 | $12,10624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Science Hill
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
- Lillian ArgentEdgewood$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.